Cochrane Abstracts
Metformin for endometrial hyperplasia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Metformin for Endometrial Hyperplasia." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432155/all/Metformin_for_endometrial_hyperplasia.
Metformin for endometrial hyperplasia. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432155/all/Metformin_for_endometrial_hyperplasia. Accessed November 22, 2024.
Metformin for endometrial hyperplasia. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432155/all/Metformin_for_endometrial_hyperplasia
Metformin for Endometrial Hyperplasia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432155/all/Metformin_for_endometrial_hyperplasia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Metformin for endometrial hyperplasia
ID - 432155
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432155/all/Metformin_for_endometrial_hyperplasia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
